Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mucocutaneous Candidiasis”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableLooking for participantsNCT01386437
What this trial is testing

Natural History of Individuals With Immune System Problems That Lead to Fungal Infections

Who this might be right for
Chronic Mucocutaneous CandidiasisInvasive AspergillosisCARD9+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Large-scale testing (Phase 3)Study completedNCT03059992
What this trial is testing

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

Who this might be right for
Invasive CandidiasisMucocutaneous CandidiasisCoccidioidomycosis+7 more
Scynexis, Inc. 233
Not applicableLooking for participantsNCT03800056
What this trial is testing

Characterization of the Fungal Origins in the Autoimmune Polyendocrinopathy of Type 1 Compared With the Autoimmune Polyendocrinopathies of Type 2

Who this might be right for
Polyendocrinopathies, Autoimmune
University Hospital, Lille 30
Testing effectiveness (Phase 2)Study completedNCT02629419
What this trial is testing

CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis

Who this might be right for
Candidiasis, Chronic Mucocutaneous
Matinas BioPharma Nanotechnologies, Inc. 4
Early research (Phase 1)Study completedNCT01842386
What this trial is testing

Rituximab for Anti-cytokine Autoantibody-Associated Diseases

Who this might be right for
Pulmonary Alveolar Proteinosis (PAP)Severe Mucocutaneous Candidiasis
National Institute of Allergy and Infectious Diseases (NIAID) 7